TB Diagnostics

Meet Yanniv and Mireille — a dynamic duo revolutionizing the way we treat about TB.

TB is currently the deadliest infectious disease in the world. An estimated 10.4 million people are diagnosed, but an additional 4.2 million people go undetected annually. Medical communities are limited by the availability of diagnostic platforms that are too expensive, time-consuming, or require technical resources and expertise.

TB Diagnostics, focuses on rapid, battery-powered and low-cost detection of infectious agents. Their non-invasive technology contains a novel stain that can detect contagious TB cells in sputum samples from patients within one hour. In our conversation, Yanniv and Mireille said:

Ultimately, we envision a global rollout and replacement of outdated, costly, and resource-rich screening tests with our technology.

Meet the team:

• Mireille Kamariza, founder and CSO, worked on the stain technology during her PhD at Stanford University. She is from Burundi, East-Africa and hopes to bring this new test to areas affected most by TB disease. In her spare time, Mireille loves trying on new cuisine or hanging out at home watching period dramas in her PJs.
• Yanniv Dorone, founder and COO, is also a PhD student at Stanford University. He has expertise in cell and molecular biology, and has been actively involved in multiple diversity initiatives, outreach events and academic committees at Stanford. Before moving to California, Yanniv lived the first half of his life in Israel and the second half in France. In his free time, Yanniv is probably either watching the news or reading the news.

If interested in TB Diagnostics, please reach out to ydorone@stanford.edu